News : Archives

Joshua M. Hare, M.D.

Stem Cells Improve Heart Function for Patients with Chronic Non-Ischemic Dilated Cardiomyopathy

Researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have discovered that allogeneic human mesenchymal stem cells are efficacious and safe when used to treat patients with chronic non-ischemic dilated cardiomyopathy, a degenerative heart condition not caused by coronary disease.

Read more on the Miller School Web site »

Camillo Ricordi, M.D.

Researchers Develop Procedure for Standardized Pancreatic Islet Cell Production at Multiple Sites

The Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine, in a collaborative study with seven other institutions around the world, has demonstrated the feasibility of large-scale production of pancreatic islet cells by multiple manufacturing sites using a standardized process. Their report was published as the cover story in the November issue of Diabetes.

Read more on the Miller School Web site »

Lina Shehadeh, Ph.D.

Miller School Cardiology Researcher Receives Federal Grant to Study Signaling in Heart Failure

A cardiology researcher at the University of Miami Miller School of Medicine has been awarded a $400,000 high-priority grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health to study cardiac signaling in heart failure.

Read more on the Miller School Web site »

Bernard S. Baumel, M.D.

Alzheimer’s Association Funds Innovative Stem Cell Trial Led by UHealth Neurologist

A first-of-its-kind trial using stem cells in Alzheimer’s disease patients that is led by UHealth – the University of Miami Health System and sponsored by Miami-based life sciences company Longeveron LLC, has received a $1 million award from the Alzheimer’s Association.

Read more on the Miller School Web site »

Marilyn K. Glassberg, M.D., speaking at the Vatican.

Dr. Marilyn K. Glassberg Presents Research Findings at Vatican Stem Cell Conference

When Marilyn K. Glassberg, M.D., professor of medicine, surgery and pediatrics, spoke at an international conference held at the Vatican, she delivered a moving account of the promising early results obtained by investigators at the University of Miami Miller School of Medicine in a small clinical trial that explored stem cell treatment in patients with idiopathic pulmonary fibrosis (IPF).

Read more on the Miller School Web site »

Page 3 of 20 pages  <  1 2 3 4 5 >  Last »